Henry Kuerer is a Surgical Oncologist in Houston, Texas. Dr. Kuerer is rated as an Elite provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.

Wendy Woodward is a Radiation Oncologist in Houston, Texas. Dr. Woodward is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Intraductal Papilloma, and Breast Cancer in Men.

Abenaa Brewster is an Oncologist and a Hematologist in Houston, Texas. Dr. Brewster is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.

Abigail Caudle is a General Surgeon and a Surgical Oncologist in Houston, Texas. Dr. Caudle is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Mastectomy.

Bora Lim is an Oncologist and a Hematologist in Houston, Texas. Dr. Lim is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, Paget Disease of the Breast, and Tissue Biopsy.

Isabelle Bedrosian is a Surgical Oncologist in Houston, Texas. Dr. Bedrosian is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Lymphadenectomy.

Dr. Julie Nangia is a medical oncologist who specializes in the care of patients with breast cancer. Dr. Nangia is Medical Director of Breast Oncology at the Breast Care Center at the Dan L Duncan Comprehensive Cancer Center and an Associate Professor of Medicine at the Lester and Sue Smith Breast Center at Baylor College of Medicine. She is also the Director of the Breast Cancer Prevention and High Risk Clinic at BCM, where she is a Faculty Senator.Dr. Nangia’s clinical interests include: hereditary breast cancer, breast cancer prevention, and metastatic triple negative breast cancer.Dr. Nangia received her medical degree from the University of Missouri-Kansas City. She completed her residency in internal medicine at The University of Texas Health Science Center in Houston and a hematology-oncology fellowship at Rush University Medical Center in Chicago, Illinois.Dr. Nangia is board certified in internal medicine and medical oncology. Dr. Nangia is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Familial Pancreatic Cancer, and HER-2 Positive Breast Cancer.

Dr. Alastair Thompson is a surgical oncologist specializing in breast cancer. He is the Professor and Chief of the Division of Surgical Oncology, Section of Breast Surgery at Baylor College of Medicine, where he holds the Olga Keith Wiess Chair of Surgery. He also serves as Co-Director of the Lester and Sue Smith Breast Center and is Co-Associate Director for Clinical Research at the Dan L Duncan Comprehensive Cancer Center.Dr. Thomspon’s clinical interests include: ductal carcinoma in situ (DCIS); nipple and skin sparing mastectomy; breast conservation surgery; and sentinel lymph node biopsy. His research interests include: multidisciplinary patient care alongside “bench to bedside” studies; and innovative clinical trials in cancer. He initiated and led a successful breast cancer laboratory program; provided leadership for a cancer center in the United Kingdom; chaired the UK national breast cancer trials portfolio of 120 studies; and engaged in a range of pivotal roles in key drug, radiation therapy and surgical trials involving the UK, Europe, United States and Australia.Dr. Thompson also has preclinical and practical experience in the design, implementation, monitoring and reporting of early- to late-phase drug and medical device trials. Dr. Thompson received his MBChB in Medicine Surgery and medical degree in Molecular Biology from the University of Edinburgh in Edinburgh, Scotland. He completed his residency in general surgery at the Royal Infirmary of Edinburgh and a Research Fellowship at the Imperial Cancer Research Fund in Edinburgh.Dr. Thompson has co-chaired the Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial for low-risk DCIS; and the National Cancer Institute (NCI)-Breast Cancer Steering Committee proposed “no surgery” clinical trial planning committee. He is a member of the NCI BOLD taskforce and has held leadership positions in the Translational Breast Cancer Research Consortium and SWOG Cancer Research Network.Dr. Thompson is also a member of the American Society of Clinical Oncology, Association of Breast Surgery, British Association of Surgical Oncology, British Breast Group, American Society of Breast Surgeons, American Association for Cancer Research, Moynihan Chirurgical Club, and the Society of Surgical Oncology. Dr. Thompson is rated as an Elite provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Tissue Biopsy.

Simona Shaitelman is a Radiation Oncologist in Houston, Texas. Dr. Shaitelman is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Intraductal Papilloma, and Angiosarcoma.

Dr. Mothaffar F. Rimawi is a board-certified medical oncologist specializing in breast cancer care and research. He is Professor at the Department of Medicine, Section of Hematology and Oncology at Baylor College of Medicine. Dr. Rimawi is also Executive Medical Director & Associate Director of Clinical Affairs and Co-Leader of the Breast Cancer Program at BCM’s Dan L Duncan Comprehensive Cancer Center. Additionally, he serves as Chief of the Oncology Service Line at St Luke's Health in Houston.Dr. Rimawi’s professional interests include: the diagnosis, treatment and management of breast cancer; clinical trials in breast cancer; neoadjuvant therapy; targeted therapy and biomarkers in breast cancer; treatment resistance to ER and HER2-targeted therapies in breast cancer; locally advanced breast cancer; and breast disease and cancer.Dr. Rimawi received his medical degree from the University of Jordan in Amman, Jordan. He completed his residency in Internal Medicine and fellowships in Medical Oncology and Hematology and Breast Cancer at BCM. Dr. Rimawi holds certifications in Internal Medicine and Medical Oncology from the American Board of Internal Medicine. He is a member of the American College of Physicians, American Society of Clinical Oncology and the American Medical Association.In addition to English, Dr. Rimawi speaks Arabic. Dr. Rimawi is rated as an Elite provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Paget Disease of the Breast.

Funda Meric is a General Surgeon and a Surgical Oncologist in Houston, Texas. Dr. Meric is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Cholangiocarcinoma (Bile Duct Cancer), Triple-Negative Breast Cancer, Melanoma, and Mastectomy.

Aman Buzdar is an Oncologist in Houston, Texas. Dr. Buzdar is rated as an Elite provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, HER-2 Positive Breast Cancer, and Menopause.

Anish Meerasahib is an Oncologist and a Hematologist Oncology provider in Houston, Texas. Dr. Meerasahib is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Breast Cancer, Paget Disease of the Breast, and Lung Cancer. Dr. Meerasahib is currently accepting new patients.

Nadya Hasham-Jiwa is an Oncologist in Houston, Texas. Dr. Hasham-Jiwa is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Hasham-Jiwa is currently accepting new patients.

Alison Rome is a Hematologist Oncology specialist and a Hematologist in Houston, Texas. Dr. Rome is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, and Inflammatory Breast Cancer. Dr. Rome is currently accepting new patients.

Gabriel Hortobagyi is an Oncologist in Houston, Texas. Dr. Hortobagyi is rated as an Elite provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Breast Cancer in Men.

Stacy Moulder is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Moulder is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Triple-Negative Breast Cancer, Breast Cancer, HER-2 Positive Breast Cancer, and Cerebral Hypoxia.

Paula Pohlmann is an Oncologist and a Hematologist Oncology provider in Houston, Texas. Dr. Pohlmann is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma.

Powel Brown is a Hematologist Oncology specialist and an Oncologist in Houston, Texas. Dr. Brown is rated as an Elite provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Salpingo-Oophorectomy.

Clinton Yam is an Oncologist in Houston, Texas. Dr. Yam is rated as an Elite provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Triple-Negative Breast Cancer, Breast Cancer, Paget Disease of the Breast, and Inflammatory Breast Cancer.